Journal of Neurochemistry · 1997 · 124 citations · 63 references
Life SciencesNeurobiologyNeuroscienceCellular NeuroscienceDevelopmental NeuroscienceNeurochemistryAstrocyte BiologyDevelopmental NeuropharmacologyDevelopmental NeurotoxicityGlial Cell BiologyNeural DevelopmentNeuroprotectionBrain ToxicityDopaminergic NeuronsDopaminergic NeuroprotectionGlial-mediated NeurotoxicityGlutathione HomeostasisGlutathione Peroxidase ActivityGlutathione Peroxidase InhibitionReduced Glutathione
L-DOPA is toxic to catecholamine neurons in culture, but the toxicity is reduced by exposure to astrocytes. We tested the effect of L-DOPA on dopamine neurons using postnatal ventral midbrain neuron/cortical astrocyte cocultures in serum-free, glia-conditioned medium. L-DOPA (50 microM) protected against dopamine neuronal cell death and increased the number and branching of dopamine processes. In contrast to embryonically derived glia-free cultures, where L-DOPA is toxic, postnatal midbrain cultures did not show toxicity at 200 microM L-DOPA. The stereoisomer D-DOPA (50-400 microM) was not neurotrophic. The aromatic amino acid decarboxylase inhibitor carbidopa (25 microM) did not block the neurotrophic effect. These data suggest that the neurotrophic effect of L-DOPA is stereospecific but independent of the production of dopamine. However, L-DOPA increased the level of glutathione. Inhibition of glutathione peroxidase by L-buthionine sulfoximine (3 microM for 24 h) blocked the neurotrophic action of L-DOPA. N-Acetyl-L-cysteine (250 microM for 48 h), which promotes glutathione synthesis, had a neurotrophic effect similar to that of L-DOPA. These data suggest that the neurotrophic effect of L-DOPA may be mediated, at least in part, by elevation of glutathione content.
63
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains
Peter Riederer, E. Sofić, Wolf‐Dieter Rausch et al. · Journal of Neurochemistry · 1989 · 1.4K citations